Expression of utrophin A mRNA correlates with the oxidative capacity of skeletal muscle fiber types and is regulated by calcineurin/NFAT signaling
about
The genetic architecture of adaptations to high altitude in EthiopiaThe role of calcium and calcium/calmodulin-dependent kinases in skeletal muscle plasticity and mitochondrial biogenesisRescue of dystrophic skeletal muscle by PGC-1α involves a fast to slow fiber type shift in the mdx mouseEmerging drugs for sarcopenia: age-related muscle wastingIRES-mediated translation of utrophin A is enhanced by glucocorticoid treatment in skeletal muscle cellsNF-kappaB mediates the transcription of mouse calsarcin-1 gene, but not calsarcin-2, in C2C12 cellsEts-2 repressor factor silences extrasynaptic utrophin by N-box mediated repression in skeletal muscle.Dystrophin deficiency in canine X-linked muscular dystrophy in Japan (CXMDJ) alters myosin heavy chain expression profiles in the diaphragm more markedly than in the tibialis cranialis muscle.Pharmacological activation of PPARbeta promotes rapid and calcineurin-dependent fiber remodeling and angiogenesis in mouse skeletal muscleTherapeutic targeting of signaling pathways in muscular dystrophy.Muscle structure influences utrophin expression in mdx mice.Signaling mechanisms in skeletal muscle: acute responses and chronic adaptations to exercise.Intronic regulation of matrix metalloproteinase-2 revealed by in vivo transcriptional analysis in ischemiaSafety, Tolerability, and Pharmacokinetics of SMT C1100, a 2-Arylbenzoxazole Utrophin Modulator, following Single- and Multiple-Dose Administration to Pediatric Patients with Duchenne Muscular Dystrophy.Viral-mediated gene therapy for the muscular dystrophies: successes, limitations and recent advancesCalcineurin and skeletal muscle growth.FOXO1 and GSK-3β Are Main Targets of Insulin-Mediated Myogenesis in C2C12 Muscle Cells.E2F transcription factor-1 deficiency reduces pathophysiology in the mouse model of Duchenne muscular dystrophy through increased muscle oxidative metabolism.Combinatorial therapeutic activation with heparin and AICAR stimulates additive effects on utrophin A expression in dystrophic muscles.Modulation of utrophin A mRNA stability in fast versus slow muscles via an AU-rich element and calcineurin signaling.Safety, tolerability, and pharmacokinetics of SMT C1100, a 2-arylbenzoxazole utrophin modulator, following single- and multiple-dose administration to healthy male adult volunteersImmune-mediated mechanisms potentially regulate the disease time-course of duchenne muscular dystrophy and provide targets for therapeutic intervention.The functional role of calcineurin in hypertrophy, regeneration, and disorders of skeletal muscle.Duchenne muscular dystrophy drug discovery - the application of utrophin promoter activation screening.Identification of differentially expressed genes in longissimus muscle of pigs with high and low intramuscular fat content using RNA sequencing.The GTPase RhoA increases utrophin expression and stability, as well as its localization at the plasma membraneOverexpression of SERCA1a in the mdx diaphragm reduces susceptibility to contraction-induced damage.Second-generation compound for the modulation of utrophin in the therapy of DMD.Pathological pattern of Mdx mice diaphragm correlates with gradual expression of the short utrophin isoform Up71.Activation of p38 signaling increases utrophin A expression in skeletal muscle via the RNA-binding protein KSRP and inhibition of AU-rich element-mediated mRNA decay: implications for novel DMD therapeutics.Changes in acetylcholine receptor function induce shifts in muscle fiber type composition.Neural regulation of acetylcholinesterase-associated collagen Q in rat skeletal muscles.Stimulation of calcineurin Aalpha activity attenuates muscle pathophysiology in mdx dystrophic mice.AMPK in skeletal muscle function and metabolism.The utrophin A 5'-untranslated region confers internal ribosome entry site-mediated translational control during regeneration of skeletal muscle fibers.Utrophin A is essential in mediating the functional adaptations of mdx mouse muscle following chronic AMPK activation.Alternative utrophin mRNAs contribute to phenotypic differences between dystrophin-deficient mice and Duchenne muscular dystrophy.
P2860
Q21563365-B0857FBD-A84D-4C7E-9544-F5D3E7C8DF48Q24300549-4DAA1B34-51CE-4C4C-8D19-C30363235E19Q27310125-B2D12EE8-067A-4D4A-B238-B939158F12CDQ28295716-871499B6-3C18-4074-B010-0D100A1459A4Q28472887-348F32F8-DE51-485C-81C0-CEA502092CC6Q33277123-A5422B7B-5B15-4F94-971F-442FD9F46061Q33284878-2F22F800-A57F-4361-997D-777884E9A2E0Q33313653-73DD9A9C-D777-430B-9B1A-9220C9FAFE8CQ33705041-BFD2CBF6-7B6D-4ED0-9B8F-16B8AEF7666FQ33707964-CCDF0FF1-1711-4427-B3C8-5FEBB0F2077CQ33747602-3BB4F38E-A6B9-4927-A3A8-9629464A7221Q33913651-FFFD06EC-8657-4A97-8B37-9C94741933C5Q34132405-5ECB9EBA-45EB-46C9-83E4-3017E0864E2AQ34521236-C9EAA636-9FEF-4C2D-BE47-B3BA853D421BQ35847178-8DC7B294-828D-4BE5-8150-AB637F655C1EQ35855992-E97B405A-C9DC-4A53-9412-EC52466883CEQ35897895-E0DD95F3-1B0A-471D-BD92-DE64DB572BDBQ36142090-F1027189-B814-4EC5-8667-B1892D9DCF4EQ36402509-71ECABD4-4C59-48FC-98E3-A4F39D17A2A4Q36457156-A5857197-0526-4576-8105-6910B93D607EQ37257485-7D1B0024-9C9C-4C2B-8577-F0F5071061B8Q37583167-79DE4629-1910-47BD-91D5-78A0DEDEDE73Q37727810-A8951981-1629-4753-9D62-D82C6A6461ADQ38087705-D49B1850-7ECE-4B30-912C-48871C9A251CQ38439434-11745911-05E0-4BFD-8E98-7CDF0D0EEAA1Q39497947-00409D4E-54C6-48A2-B2B7-D248E38D6393Q41118342-4E105161-EAFF-4A7B-939C-0B8993C478A4Q41374222-DC217606-A3AB-4C51-8871-EB4E2760E72EQ42379475-FBF44885-F507-4D42-947B-387164D2FCC3Q45328178-C333E3D5-5482-40CD-A799-C8D97209F99FQ46667972-72552777-1376-4E4A-83BC-71C22B13F18BQ46676508-93C3304F-BB92-4079-88C6-C98A35661B3BQ46805060-E425C444-74AB-4B60-8702-773188941921Q47781006-580D9CB2-7EF5-4775-8A89-C040E171B118Q54650956-66442E52-8A40-49AE-8F79-189EA18AEA8AQ55070574-976FB7EC-8E74-4279-9887-B4919E6447B8Q55622381-FBB4845A-8CFD-4416-82DA-E641FE84A721
P2860
Expression of utrophin A mRNA correlates with the oxidative capacity of skeletal muscle fiber types and is regulated by calcineurin/NFAT signaling
description
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
article publié dans les Procee ...... f the United States of America
@fr
artículu científicu espublizáu en 2003
@ast
im Juni 2003 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2003/06/24)
@sk
vědecký článek publikovaný v roce 2003
@cs
wetenschappelijk artikel (gepubliceerd op 2003/06/24)
@nl
наукова стаття, опублікована в червні 2003
@uk
name
Expression of utrophin A mRNA ...... by calcineurin/NFAT signaling
@ast
Expression of utrophin A mRNA ...... by calcineurin/NFAT signaling
@en
Expression of utrophin A mRNA ...... by calcineurin/NFAT signaling
@nl
type
label
Expression of utrophin A mRNA ...... by calcineurin/NFAT signaling
@ast
Expression of utrophin A mRNA ...... by calcineurin/NFAT signaling
@en
Expression of utrophin A mRNA ...... by calcineurin/NFAT signaling
@nl
prefLabel
Expression of utrophin A mRNA ...... by calcineurin/NFAT signaling
@ast
Expression of utrophin A mRNA ...... by calcineurin/NFAT signaling
@en
Expression of utrophin A mRNA ...... by calcineurin/NFAT signaling
@nl
P2093
P2860
P50
P3181
P356
P1476
Expression of utrophin A mRNA ...... by calcineurin/NFAT signaling
@en
P2093
Bernard J Jasmin
Eva R Chin
Julie Deschenes-Furry
Lindsay M Angus
Mark A Stocksley
Robin N Michel
Simon St-Pierre
P2860
P304
P3181
P356
10.1073/PNAS.0932671100
P407
P577
2003-06-13T00:00:00Z